As Brussels seeks a new supply contract with Pfizer from 2022, the US pharmaceutical giant has hiked its EU prices on future orders of its vaccine, potentially raising the cost by more than 60%, to some $23 per dose.
Note to readers: Please click the share buttons above or below. Follow us on Instagram, @crg_globalresearch. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.
Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article.